Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research
By Simone Rossi, Mark Hallett, Paolo Maria Rossini, Alvaro Pascual-Leone. Clinical Neurophysiology, 2009
5,087 citations recorded by the source corpus.
This article is based on a consensus conference, which took place in Certosa di Pontignano, Siena (Italy) on March 7–9, 2008, intended to update the previous safety guidelines for the application of transcranial magnetic stimulation (TMS) in research and clinical settings. Over the past decade the scientific and medical community has had the opportunity to evaluate the safety record of research studies and clinical applications of TMS and repetitive TMS (rTMS). In these years the number of applications of conventional TMS has grown impressively, new paradigms of stimulation have been developed (e.g., patterned repetitive TMS) and technical advances have led to new device designs and to the real-time integration of TMS with electroencephalography (EEG), positron emission tomography (PET) and functional magnetic resonance imaging (fMRI). Thousands of healthy subjects and patients with various neurological and psychiatric diseases have undergone TMS allowing a better assessment of relative risks. The occurrence of seizures (i.e., the most serious TMS-related acute adverse effect) has been extremely rare, with most of the few new cases receiving rTMS exceeding previous guidelines, often in patients under treatment with drugs which potentially lower the seizure threshold. The present updated guidelines review issues of risk and safety of conventional TMS protocols, address the undesired effects and risks of emerging TMS interventions, the applications of TMS in patients with implanted electrodes in the central nervous system, and safety aspects of TMS in neuroimaging environments. We cover recommended limits of stimulation parameters and other important precautions, monitoring of subjects, expertise of the rTMS team, and ethical issues. While all the recommendations here are expert based, they utilize published data to the extent possible.
Subfields: Biomedical Engineering, Neurology
View Paper: https://www.semanticscholar.org/paper/bbfccff8e5787c90ddc29813cc83355e10beb38a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- John C. Rothwell
- Ulf Ziemann
- Michael A. Nitsche
- Walter Paulus
- M. D'esposito
- Mattia F. Pagnotta
- Mark Hallett
- Paolo Maria Rossini
In Neurology
- Leonardo G. Cohen
- John C. Rothwell
- Alvaro Pascual-Leone
- Michael A. Nitsche
- Walter Paulus
- Ulf Ziemann
- Hartwig Roman Siebner
- Mark Hallett
Citations in the corpus
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “…treatments, there is a risk of manic switch with rTMS treatment in patients with bipolar disorder, although the risk of this is considered low (Rossi et al., 2009), and patients with metal implants from neurosurgery or pacemakers may be unsuitable for rTMS due to risks of interference from…”
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016, background): “Stimulation above this level falls outside conventional safety guidelines.(21) Newer theta-burst stimulation (TBS) protocols are more commonly delivered at lower intensities (e.”
- Default Mode Network Mechanisms of Transcranial Magnetic Stimulation in Depression (2014, background): “For patients who either fail to respond to an antidepressant or experience intolerable side effects, TMS is a potentially useful alternative that is both well tolerated (2) and effective (7,8).”
- Combining non-invasive transcranial brain stimulation with neuroimaging and electrophysiology: Current approaches and future perspectives (2016, neutral): “…application to derive stimulation parameter information Stimulation intensity is certainly among the most essential parameters to be adjusted, as it impacts not only the effectiveness but also the safety of a certain NTBS protocol (Miranda, 2013; Nitsche et al., 2008; Rossi et al., 2009).”
- The role of interneuron networks in driving human motor cortical plasticity. (2013, methodology): “The resting motor threshold (RMT) with PA currents (RMTpa) was defined as the minimum stimulation intensity over the motor hot-spot, required to evoke an MEP of no less than 50 μV in 5 out of 10 trials (Rossi et al. 2009).”
- Rehabilitation of Motor Function after Stroke: A Multiple Systematic Review Focused on Techniques to Stimulate Upper Extremity Recovery (2016, neutral): “The safety and application guidelines of transcranial magnetic stimulation were extensively reviewed by Rossi et al. (2009).”
- The necessity of rostrolateral prefrontal cortex for higher-level sequential behavior (2015, positive): “All stimulus output and timing parameters were within established safe ranges (Rossi et al., 2009).”